EpiGlo PDGF MATRIX

EpiGlo PDGF MATRIX — Matrix-Binding Growth Factor Fusion. Recombinant PDGF-BB with a PlGF-derived matrix-binding domain. In development. Planned pricing from $399.00 USD; contact TheraGene for current status and future availability.

Description

EPI-GLO® BY THERAGENE   ·   Biology, Beautifully Refined.
EPI-GLO® · PDGF-BB · Matrix-binding design

PDGF MATRIX

Designed to connect.

A development concept pairing recombinant PDGF-BB with a PlGF-derived domain, with a focus on extracellular-matrix affinity.

From$399.00USD

Planned starting price. In development; not currently available for purchase.

  • Recombinant PDGF-BB
  • PlGF-derived domain
  • In development
ENQUIRE ABOUT PDGF MATRIX

Ask about development progress and future availability.

Discover PDGF MATRIX
Product overview

PDGF MATRIX is in development. Its molecular design combines recombinant PDGF-BB with a PlGF-derived matrix-binding domain. Matrix affinity is a development objective; product-specific safety, performance and suitability require evaluation. This is not a claim of clinical superiority.

Pack options & ordering

Contact TheraGene for current pack formats, contents and availability. Prices start at $399.00 USD; your final quote will specify the selected format, shipping and any applicable taxes. No payment is collected through an inquiry.

Directions & storage

Follow the applicable product label for preparation, use and storage. epiGlo topical products are for external cosmetic use only, not for injection or use in the eyes. Request the current product information before use.

The thinking behind PDGF MATRIX

Designed to connect.

PDGF MATRIX is in development. Its molecular design combines recombinant PDGF-BB with a PlGF-derived matrix-binding domain. Matrix affinity is a development objective; product-specific safety, performance and suitability require evaluation. This is not a claim of clinical superiority.

Explore the formulation direction

Product Use & Scientific Information

epiGlo topical cosmetic products are intended for external cosmetic use only. They are not intended to diagnose, treat, cure, mitigate, or prevent disease, or to replace medical care. Not for injection, ingestion, or use in the eyes. Follow all product-specific directions, warnings, preparation requirements, and storage instructions. Discontinue use if an adverse reaction occurs and seek appropriate medical advice.

Information on this website is provided for educational and product-information purposes and does not constitute medical advice or a treatment protocol. References to professional use or aesthetic procedures do not establish suitability for microneedling, laser-assisted delivery, or application to broken or recently treated skin.

Scientific references concern the specific ingredients, technologies, formulations, and conditions studied. Research involving individual ingredients, laboratory or animal models, or other formulations does not, by itself, establish the safety, performance, skin penetration, or clinical benefits of a finished epiGlo product. Descriptions of molecular design and proposed mechanisms do not establish clinical superiority. No FDA approval or endorsement is claimed.

Individual cosmetic results vary, and specific outcomes are not guaranteed. Campaign portraits, animations, and concept packaging are illustrative; they do not depict patient testimonials, before-and-after results, or evidence of product performance. Products identified as development concepts, including PDGF MATRIX, remain subject to evaluation. Confirm current product status, specifications, and availability with TheraGene.

Reviews

There are no reviews yet.

Be the first to review “EpiGlo PDGF MATRIX”

Your email address will not be published. Required fields are marked *